Zepbound (Tirzepatide): The newest player, approved for weight management, hovers around $1,000 to $1,200 per month
To get closer to cause-and-effect answers, researchers conducted a target-trial emulation in 2025
News Release April 22, 2004 ConsumerLab.com shares insights from 2 years of testing supplements for athletic banned substances Athletes and manufacturers urged to learn how to avoid problems WHITE PLAINS, NY April 22, 2004 Two years after initiating the first program to test dietary supplements for substances banned from athletic competition, ConsumerLab.com today released a short advisory summarizing problems uncovered to-date from its testing
However, even moderate weight loss should be managed with attention to nutritional adequacy
Decision fatigue is a common challenge when on a GLP-1, especially when appetite is low, she says
Growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells